Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Cumulative Translation Adjustment	Total
Balance at Dec. 31, 2019	$ 1,012	$ 14,610,638	$ (12,215,642)		$ 2,396,008
Balance (in Shares) at Dec. 31, 2019	10,119,844
Issuance of common stock and warrants	$ 145	4,193,611			4,193,756
Issuance of common stock and warrants (in Shares)	1,449,275
Issuance of common stock (net of offering costs of $525,000)	$ 182	4,474,818			4,475,000
Issuance of common stock (net of offering costs of $525,000) (in Shares)	1,818,182
Cancellation of common stock	$ (2)	2
Cancellation of common stock (in Shares)	(15,000)
Warrant exercise	$ 6	56,244			56,250
Warrant exercise (in Shares)	56,250
Stock-based compensation		737,746			737,746
Stock-based compensation (in Shares)	9,984
Cumulative translation adjustment				(15,351)	(15,351)
Net loss			(7,197,816)		(7,197,816)
Balance at Dec. 31, 2020	$ 1,343	24,073,059	(19,413,458)	(15,351)	4,645,593
Balance (in Shares) at Dec. 31, 2020	13,438,535
Issuance of common stock, common stock warrants and prefunded warrants (net of offering costs of $1,591,600)	$ 683	13,406,949			13,407,632
Issuance of common stock, common stock warrants and prefunded warrants (net of offering costs of $1,591,600) (in Shares)	6,826,962
Issuance of common stock and warrants	$ 248	4,427,253			4,427,501
Issuance of common stock and warrants (in Shares)	2,475,248
Warrant exercise	$ 113	359,400			359,513
Warrant exercise (in Shares)	1,126,720
Stock-based compensation	$ 11	1,322,810			1,322,821
Stock-based compensation (in Shares)	107,081
Cumulative translation adjustment				32,937	32,937
Net loss			(14,313,705)		(14,313,705)
Balance at Dec. 31, 2021	$ 2,398	$ 43,589,471	$ (33,727,163)	$ 17,586	$ 9,882,292
Balance (in Shares) at Dec. 31, 2021	23,974,546